Orgenesis (NASDAQ:ORGS) reported quarterly losses of $(0.29) per share. This is a 270.59 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $141.00 thousand which missed the analyst consensus estimate of $12.00 million by 98.83 percent. This is a 98.00 percent decrease over sales of $7.04 million the same period last year.
Orgenesis Q1 EPS $(0.29) Down From $0.17 YoY, Sales $141.00K Miss $12.00M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.